Abstract
Significant evidence implicates the endogenous opioid system (EOS) (opioid peptides and receptors) in the mechanisms underlying the psychopharmacological effects of ethanol. Ethanol modulates opioidergic signaling and function at different levels, including biosynthesis, release, and degradation of opioid peptides, as well as binding of endogenous ligands to opioid receptors. The role of β-endorphin and µ-opioid receptors (OR) have been suggested to be of particular importance in mediating some of the behavioral effects of ethanol, including psychomotor stimulation and sensitization, consumption and conditioned place preference (CPP). Ethanol increases the release of β-endorphin from the hypothalamic arcuate nucleus (NArc), which can modulate activity of other neurotransmitter systems such as mesolimbic dopamine (DA). The precise mechanism by which ethanol induces a release of β-endorphin, thereby inducing behavioral responses, remains to be elucidated. The present review summarizes accumulative data suggesting that the first metabolite of ethanol, the psychoactive compound acetaldehyde, could participate in such mechanism. Two lines of research involving acetaldehyde are reviewed: (1) implications of the formation of acetaldehyde in brain areas such as the NArc, with high expression of ethanol metabolizing enzymes and presence of cell bodies of endorphinic neurons and (2) the formation of condensation products between DA and acetaldehyde such as salsolinol, which exerts its actions via OR.
Ethanol and the opioid system
Evidence indicates that ethanol modulates the activity of different components of the endogenous opioid system (EOS), with a large body of data supporting the implication of opioid ligands and receptors in the mediation of some of the psychopharmacological effects of ethanol.
The endogenous opioid system at a glance
The opioid peptide precursors proopiomelanocortin (POMC), proenkephalin (PENK) or prodynorphin (PDYN) (Kieffer and Gavériaux-Ruff, 2002) are the source for the respective peptides β-endorphin, enkephalin, and dynorphin (Nylander and Roman, 2012). These endogenous ligands activate G-protein-coupled µ-, ∂-, and κ-opioid receptors (OR) (µ-OR, ∂-OR and κ-OR), which differ in their affinities and response profiles (Evans et al., 1992; Knapp et al., 1995; Kieffer and Evans, 2009). β-endorphin presents higher affinity for µ- than ∂-, and reduced affinity for κ-OR (Roth-Deri et al., 2008; Trigo et al., 2010). Enkephalin binding to ∂-OR is greater than that for µ-OR (Khachaturian et al., 1985; Raynor et al., 1994; Akil et al., 1998) and dynorphin shows specific affinity for κ-OR (Chavkin et al., 1982; Simon, 1991; Roth-Deri et al., 2008; Trigo et al., 2010). Ethanol can modulate opioidergic transmission at different levels, including synthesis, release, and degradation of opioid peptides, and binding of endogenous ligands to OR (for a review see, Méndez and Morales-Mulia, 2008). Since β-endorphin signaling has been specially implicated in the behavioral effects of ethanol, the present review will focus on the effects of ethanol on this component of the EOS. In this regard, although OR and ligands are widely distributed through the brain, there are important neuroanatomical determinants related to β-endorphin distribution that are worth highlighting. β-endorphin-synthesizing cell bodies are primarily located in the hypothalamic arcuate nucleus (NArc) (Chronwall, 1985). Important brain regions for drug-induced effects such as the nucleus accumbens (NAcb) are under tonic control of β-endorphinic innervations from the NArc (Chronwall, 1985; Khachaturian et al., 1985; Spanagel et al., 1992; Gianoulakis, 2001). These NArc β-endorphin projections exert this control through the direct activation of OR located at the NAcb and by an indirect pathway via OR in the ventral tegmental area (VTA), which in turn modulate NAcb activity via VTA-NAcb dopamine (DA) neurons (Mansour et al., 1988; Di Chiara and North, 1992; Spanagel et al., 1992).
Ethanol-induced modulation of β-endorphinic neurotransmission
Acute administration of ethanol induces the release of β-endorphin; an effect found in hypothalamic cell cultures and tissue preparations (Gianoulakis, 1990; Boyadjieva and Sarkar, 1994; de Waele et al., 1994; Reddy et al., 1995; De et al., 2002). Ethanol also produces in vivo increases in β-endorphin content at the level of the hypothalamus (Schulz et al., 1980; Patel and Pohorecky, 1989), NAcb (Anwer and Soliman, 1995; Olive et al., 2001; Marinelli et al., 2003a), midbrain including the VTA (Rasmussen et al., 1998; Jarjour et al., 2009) and the central amygdala (CeA) (Lam et al., 2008). Some studies, however, have found inconsistent results, probably related to procedural and methodological differences (Seizinger et al., 1983; Popp and Erickson, 1998; Rasmussen et al., 1998; Leriche and Méndez, 2010). Increased levels of enkephalin in the hypothalamus (Schulz et al., 1980; Seizinger et al., 1983; Milton et al., 1991) and NAcb (Marinelli et al., 2003b) have also been found after acute ethanol.
Long-term exposure to ethanol primarily induces a decrease in POMC expression (Boyadjieva and Sarkar, 1997; Rasmussen et al., 2002; Oswald and Wand, 2004) and in hypothalamic β-endorphin release and levels (Boyadjieva and Sarkar, 1994; Oswald and Wand, 2004). A limited number of studies reported an increase in biosynthesis of POMC and POMC mRNA expression (Seizinger et al., 1984; Gianoulakis et al., 1988) as well as an initial increase followed by a gradual return to normal levels (Wand, 1990). Also, some authors found an increase or no effect on β-endorphin release (Boyadjieva and Sarkar, 1994; Oswald and Wand, 2004). Discrepancies might be attributable to the method of ethanol administration, ethanol dose, time course of drug exposure, administration route and differences in the development of tolerance. Also, it has been observed that alcohol-induced changes depend on the brain region investigated as well as the species and strain of animals used (Gianoulakis, 2001; Méndez and Morales-Mulia, 2008).
Evidence of behavioral effects of ethanol mediated by the endogenous opioid system
Given that β-endorphin, and also enkephalin, activate μ-OR, extensive research has investigated the role of μ-OR in the behavioral effects of ethanol (Gianoulakis, 1993; Herz, 1997; Sanchis-Segura et al., 2000; Thorsell, 2013). Here we will focus on the involvement of these components of the EOS in several behavioral effects of ethanol, including psychomotor stimulation and sensitization, consumption, and associative learning (with a special focus on conditioned place preference (CPP)).
Psychomotor stimulation and sensitization
Increased psychomotor stimulation induced by ethanol in mice can be blocked with non-selective opioid receptor antagonists such as naloxone or naltrexone (Kiianmaa et al., 1983; Camarini et al., 2000; Sanchis-Segura et al., 2004; Pastor et al., 2005; Pastor and Aragon, 2006). Some pharmacological strategies have suggested the existence of three so-called subtypes of µ-OR; µ1, µ2, and, µ3 (Pasternak, 2001a,b; Cadet et al., 2003) and several studies have shown that μ- and specifically the µ1/2 - and µ3-OR subtypes, but not δ- or κ-OR, are involved in the motor stimulant effects of ethanol in adult mice (Pastor et al., 2005), and also in rats during early development (Arias et al., 2010; Pautassi et al., 2012). Other studies conducted in mice have suggested that this involvement of μ-OR in ethanol stimulation is debatable (Cunningham et al., 1998; Gevaerd et al., 1999; Holstein et al., 2005). Consistent with the EOS involvement, however, a lesion of the NArc produces a decrease in ethanol-induced stimulation in mice (Sanchis-Segura et al., 2000), and knockout mice deficient in β-endorphin showed attenuated ethanol-induced stimulation (Dempsey and Grisel, 2012). Also, in rats, naltrexone prevents activation produced by ethanol when locally administered in the NArc (Pastor and Aragon, 2008) and intra-VTA blockade of the μ-OR using either naltrexone or the irreversible and selective μ-OR antagonist β-funaltrexamine reduces ethanol-induced locomotor stimulation (Sánchez-Catalán et al., 2009). Additionally, chronic naltrexone, which upregulates μ-OR (Unterwald et al., 1998; Lesscher et al., 2003), enhances the stimulant effects of ethanol in mice (Sanchis-Segura et al., 2004).
A critical role of the EOS in the motor sensitizing effects of ethanol has also been proposed (Camarini et al., 2000; Miquel et al., 2003; Pastor and Aragon, 2006). Unspecific OR antagonism prevents development (Camarini et al., 2000) but not expression (Abrahao et al., 2008) of ethanol-induced locomotor sensitization. μ-OR are particularly involved in ethanol sensitization (Camarini et al., 2000), without a clear role of any of the µ-OR subtypes in mediating this process; µ1/2 -OR antagonism slowed down, but did not block development of sensitization (Pastor and Aragon, 2006). Facilitation of ethanol-induced sensitization found after a period of voluntary alcohol consumption in mice was also seen to be absent in μ-OR deficient CXBK mice (Tarragón et al., 2012). The involvement of μ-OR in ethanol sensitization might be related to ethanol-induced increases in β-endorphin release as a recent study demonstrated that β-endorphin-deficient mice do not show locomotor sensitization to ethanol (Dempsey and Grisel, 2012). Also, animals with selective lesions of the NArc show prevented sensitization to ethanol (Miquel et al., 2003; Pastor et al., 2011). Altogether these data suggest that opioids and specifically β-endorphins, via μ-OR, might be critical mediators of ethanol-induced neuroplasticity underlying psychomotor sensitization.
Ethanol consumption
Numerous studies conducted during the last few decades showed that systemic, as well as local administration of opioid antagonists decrease ethanol consumption under a variety of schedules in different animal species (for reviews see Herz, 1997; Gianoulakis, 2001; Oswald and Wand, 2004; Modesto-Lowe and Fritz, 2005). These conclusions have also been supported by the use of OR knockout mouse models (Roberts et al., 2000; Méndez and Morales-Mulia, 2008). This strong pre-clinical basis has lead to the use of opioid antagonists in alcoholism pharmacotherapy (O’Malley et al., 1992). In rodents, the use of non-selective, as well as selective μ-OR antagonists proved to be effective at reducing ethanol consumption (Méndez and Morales-Mulia, 2008). However, the effects of these manipulations have been seen to be, in some cases, non-specific; fat, saccharin, sucrose and water intake were also reduced by these manipulations (Krishnan-Sarin et al., 1995; Nielsen et al., 2008; Rao et al., 2008; Simms et al., 2008; Corwin and Wojnicki, 2009; Wong et al., 2009). These data are compatible with the interpretation that OR, and especially μ-OR might be a key mediator of the processing of positive reinforcement, both at emotional and motivational levels (Herz, 1997; Peciña and Berridge, 2005).
In general, data obtained with κ-OR or δ-OR manipulations are less conclusive. A recent review of the literature indicates that κ-OR stimulation generally antagonizes the reinforcing effects of alcohol whereas κ-OR blockade has no consistent effect (Wee and Koob, 2010). Dynorphin/κ-OR system appears to be involved in the negative reinforcing effects of ethanol by producing an aversive effect rather than by directly modulating the rewarding mechanism of ethanol (Wee and Koob, 2010; Walker et al., 2012). However, under an alcohol dependent-state, antagonism of κ-OR results effective in decreasing ethanol voluntary consumption (Wee and Koob, 2010; Walker et al., 2012). It has been reported that blockade of δ-OR either attenuates (Lê et al., 1993; Froehlich, 1995; Krishnan-Sarin et al., 1995; June et al., 1999; Hyytiä and Kiianmaa, 2001; Ciccocioppo et al., 2002), increases (Margolis et al., 2008) or has no effect on ethanol intake (Ingman et al., 2003). These discrepancies may be related to dynamic changes in δ-OR efficacy during ethanol exposure (Margolis et al., 2008). All these data support the participation of the POMC and PENK systems in maintaining alcohol consumption (Froehlich et al., 1991; Vengeliene et al., 2008).
Associative learning and conditioned place preference
It has been suggested that the EOS participates in the underlying mechanisms mediating conditioned effects induced by abused drugs, including ethanol. This implication is supported by two groups of experiments. On one hand, evidence indicates that OR antagonists attenuate cue-induced reinstatement of previously extinguished responding for ethanol self-administration (Lê et al., 1999; Ciccocioppo et al., 2002, 2003; Liu and Weiss, 2002; Burattini et al., 2006; Dayas et al., 2007; Marinelli et al., 2009), which suggests a role of EOS in cue-induced incentive motivational effects influencing ethanol-seeking behavior. This interpretation is consistent with clinical data showing that opioid antagonists increase abstinence duration periods in alcohol abusers (O’Malley et al., 1992), probably by reducing cue-induced seeking behavior. On the other hand, pretreatment with opioid receptor antagonism, while not influencing the acquisition of ethanol-induced CPP, reduces the expression and facilitates the extinction of this drug-free conditioned response (Bormann and Cunningham, 1997; Middaugh and Bandy, 2000; Kuzmin et al., 2003; Pastor et al., 2011). Mice lacking μ-OR also showed attenuated ethanol CPP (Hall et al., 2001). Further studies have suggested that expression of ethanol-induced CPP depends on OR located in the VTA, CeA, as well as anterior cingulated cortex (Bechtholt and Cunningham, 2005; Bie et al., 2009; Gremel et al., 2011). Additionally, a neurotoxic lesion of the β-endorphin neurons of the NArc, showed a facilitated extinction of ethanol-induced CPP (Pastor et al., 2011). β-endorphin and μ-OR appear to be therefore critically involved in the mechanisms underlying ethanol CPP. As Cunningham and collaborators have suggested, it is possible that altered opioid signaling might in turn alter conditioned motivation that normally maintains cue-induced seeking behavior during CPP testing (Cunningham et al., 1998). It is interesting to mention that pharmacological blockade of δ-OR with naltrindole in the CeA reduces expression of CPP induced by ethanol in rats (Bie et al., 2009). Activation of κ-OR has been shown to blunt acquisition of ethanol CPP (Logrip et al., 2009). Supporting these results, κ-OR knockout mice also showed enhanced ethanol CPP (Femenía and Manzanares, 2012).
Acetaldehyde: a psychoactive metabolite
The specific mechanism by which ethanol modulates the activity of the EOS remains to be understood. Evidence indicates that one possible mechanism might involve the role of acetaldehyde, the first metabolite of ethanol (Miquel et al., 2003; Sanchis-Segura et al., 2005b; Pastor and Aragon, 2008). Acetaldehyde is a psychoactive compound that produces behavioral and neurochemical effects suggested to mediate at least some of the effects of ethanol. Acetaldehyde is self-administered orally (Peana et al., 2010, 2012; Cacace et al., 2012) and directly into the brain (Brown et al., 1979; McBride et al., 2002; Rodd-Henricks et al., 2002; Peana et al., 2011). Its administration induces CPP (Smith et al., 1984; Quertemont and De Witte, 2001; Peana et al., 2009; Spina et al., 2010) as well as behavioral stimulation and sensitization when centrally administered (Arizzi et al., 2003; Correa et al., 2003a,b, 2009; Rodd et al., 2005; Arizzi-LaFrance et al., 2006; Sánchez-Catalán et al., 2009). The oxidation of ethanol to acetaldehyde in the brain is essentially mediated by the catalase-H2O2 system (Aragon et al., 1992a; Gill et al., 1992). Reduced brain catalase activity, which have been seen to decrease ethanol-derived central acetaldehyde formation in brain tissue preparations (Hamby-Mason et al., 1997) and in the brain of free-moving rats (Jamal et al., 2007), decreases ethanol consumption (Aragon and Amit, 1992; Koechling and Amit, 1994; Correa et al., 2004; Karahanian et al., 2011), ethanol-induced locomotor stimulation (Aragon et al., 1992b; Correa et al., 1999b, 2004; Sanchis-Segura et al., 1999a,b,c; Pastor et al., 2002; Pastor and Aragon, 2008), the anxiolityc effects of alcohol (Correa et al., 2008) and modulates ethanol-induced CPP (Font et al., 2008). Strategies aimed at increasing the production of brain acetaldehyde via an enhancement in activity of the enzymatic catalase system have also been used. These manipulations produced an increase in the motor stimulant properties of ethanol in mice (Correa et al., 1999a, 2000; Pastor et al., 2002). Other ethanol-induced effects such as taste aversion (Aragon et al., 1985) and social memory recognition have also been seen to be modulated by changes in brain catalase (Manrique et al., 2005).
Apart from brain catalase manipulation, the direct inactivation of acetaldehyde has also been shown to reduce ethanol effects, including drinking (Font et al., 2006a) and alcohol-induced relapse drinking (Orrico et al., 2013), CPP (Font et al., 2006b; Peana et al., 2008) and motor stimulation (Font et al., 2005; Martí-Prats et al., 2010; Pautassi et al., 2011).
Acetaldehyde-induced changes in the opioidergic neurotransmission
The NArc, the main site of β-endorphin synthesis in the brain, is one of areas with the highest levels of catalase expression (Moreno et al., 1995; Zimatkin and Lindros, 1996) and lower levels of the acetaldehyde-degrading enzyme aldehyde dehydrogenase (Zimatkin et al., 1992). Therefore, it has been thus suggested that catalase-dependent formation of acetaldehyde into the NArc might mediate ethanol-induced increases in the release of β-endorphin from the NArc in turn activating OR at the level of the VTA/NAcb to stimulate behavioral and neurophysiological actions (Sanchis-Segura et al., 2005a; Pastor and Aragon, 2008). Supporting this hypothesis, several authors (Reddy and Sarkar, 1993; Pastorcic et al., 1994; Reddy et al., 1995) have demonstrated that ethanol-induced increases in hypothalamic β-endorphin release are, indeed, mediated by acetaldehyde (Reddy and Sarkar, 1993; Pastorcic et al., 1994; Reddy et al., 1995). Hypothalamic cell cultures exposed to ethanol (12.5–100 µM) led to the formation of acetaldehyde (8–24 µM) and similar concentrations of acetaldehyde (12.5–50 µM) were able to stimulate β-endorphin release when tested in the absence of ethanol (Reddy and Sarkar, 1993; Pastorcic et al., 1994). Moreover, pre-treatment of hypothalamic cell cultures with catalase inhibitors caused dose-dependent decreases in ethanol-stimulated β-endorphin secretion (Reddy et al., 1995).
Another line of research linking the EOS and acetaldehyde is the investigation of the actions of salsolinol (for a review see Hipólito et al., 2012), the condensation product of DA and acetaldehyde. Salsolinol has been shown to alter enkephalin-receptor site binding (Lucchi et al., 1982) and other OR an effect that is blocked by naloxone (Fertel et al., 1980). Interestingly, intra-NAcb administration of salsolinol increases DA levels when microinjected in the core and decreases DA levels if the administration is in the NAcb shell (Hipólito et al., 2009) in a similar way to μ- and δ-OR agonists (Hipólito et al., 2008). It has been demonstrated that μ1-OR receptors exert a tonic modulatory control over activity of the DA system (Di Chiara and North, 1992; Devine et al., 1993). Thus, one possible mechanism by which salsolinol exerts its effects on the OR could be disinhibiting DA neurons in the VTA. Upholding this hypothesis, intra-posterior VTA administration of salsolinol induces a μ-OR dependent increase in DA levels in the NAcb shell (Hipólito et al., 2011). Accordingly, it has been recently shown that salsolinol excites DA neurons of the VTA, by activating µ-OR on local GABA interneurons (Xie et al., 2012).
Evidence of behavioral effects of acetaldehyde mediated by the endogenous opioid system
Whereas accumulating evidence indicates that the EOS participates in the behavioral effects of ethanol, only few studies have studied the involvement of this system in acetaldehyde effects. Self-administration of acetaldehyde appears to be mediated by the EOS; high doses of naloxone reduced intravenous acetaldehyde self-administration in rats, and naltrexone reduced the maintenance, the deprivation effect, and operant break points of acetaldehyde voluntary consumption (Myers et al., 1984; Peana et al., 2011). Treatment with naloxonazine, a specific µ1-OR antagonist reduces maintenance of acetaldehyde oral self-administration (Peana et al., 2011). Blockade of μ-OR using either naltrexone or the irreversible and selective μ-OR antagonist β-funaltrexamine suppress the locomotor stimulation effect of acetaldehyde when microinjected into the rat posterior VTA (Sánchez-Catalán et al., 2009). Additionally, Hipólito et al. (2010) have provided data supporting the hypothesis that acetaldehyde may mediate the actions of ethanol through a mechanism dependent on μ-OR activation. These authors showed that intra-posterior VTA injections of salsolinol induced locomotor stimulation and sensitization in rats; stimulation (but not sensitization) was prevented by μ-OR antagonism. Finally, Sanchis-Segura et al. (2005b) demonstrated that administration of a catalase inhibitor directly into the NArc is sufficient to prevent the effects of ethanol on rat locomotion. Conversely, locomotor stimulation induced by ethanol injected directly into the NArc, was prevented by catalase inhibition or naltrexone, indicating a link between the behavioral effects of a reduction in acetaldehyde formation and the antagonism of μ-OR (Pastor and Aragon, 2008). The NArc, therefore, may represent a critical site to link two independent but related hypotheses: (1) the hypothesis proposing that acetaldehyde may mediate some of the psychopharmacological actions attributed to ethanol (Aragon et al., 1992a; Smith et al., 1997; Quertemont et al., 2005; Correa et al., 2012) and (2) the hypothesis that suggests that the β-endorphin/µ-OR system participate in the reinforcing and psychomotor effects of ethanol (Stinus et al., 1980; Herz, 1997; Gianoulakis, 2001; Sanchis-Segura et al., 2005b; Pastor and Aragon, 2008). Early findings also suggested a role of the opioidergic system in mediating CPP induced by salsolinol in rats (Matsuzawa et al., 2000). Antagonism of μ-OR attenuated CPP induced by salsolinol when achieved under fear stress (Matsuzawa et al., 2000). Moreover, intra-posterior VTA administration of salsolinol, that produced CPP in rats, also produced an increase in DA in the NAcb that was suppressed by β-funaltrexamine administration (Hipólito et al., 2011).
Summary and perspectives
In the present review we have summarized consistent results indicating that the EOS, and particularly β-endorphin and μ-OR, are critically involved in the psychopharmacological effects of ethanol. Additionally, we have reviewed a large body of data that indicates that the first metabolite of ethanol, acetaldehyde, might be responsible for the activation of β-endorphin release and μ-OR signaling after ethanol administration. There are two main lines of research suggesting a link between acetaldehyde and the EOS: (1) formation of acetaldehyde in brain areas such as the NArc, with high expression of ethanol metabolizing enzymes and presence of cell bodies of endorphinic neurons and (2) the formation of condensation products between DA and acetaldehyde such as salsolinol, which exerts its actions via μ-OR. To a certain degree both lines of research show important incompatibility. The fact that the lesions of the NArc are sufficient to block ethanol-induced behaviors challenge the putative role of salsolinol formed in other non-hypothalamic areas. Future studies will need to explore how to reconcile those two sets of data, and to clarify what is sufficient and/or necessary for acetaldehyde to induce behavioral responses mediated by the EOS. Finally, it is interesting to mention that most of the data suggesting a role of the EOS in acetaldehyde-induced behavioral effects have been linked to acetaldehyde-induced changes in the opioid system that are suggested to impact behavior via modulation of the DA system (Peana et al., 2011). Ethanol as well as acetaldehyde activate firing of dopaminergic neurons in the VTA (Foddai et al., 2004; Diana et al., 2008) and stimulate DA transmission in the NAcb (Melis et al., 2007; Enrico et al., 2009; Sirca et al., 2011), effects that are prevented by D-penicillamine, a sequestering agent of acetaldehyde (Enrico et al., 2009). A recent study demonstrates that in rats, ethanol and acetaldehyde induce via DA D1 receptors, ERK phosphorylation in the NAcb and extended amygdala (Vinci et al., 2010). This effect is blocked by D-penicillamine and by naltrexone, suggesting that the opiodergic modulation of the reinforcing properties of acetaldehyde could be mediated by the dopaminergic system (Vinci et al., 2010; Peana et al., 2011). There are other effects such as ethanol-induced CPP, ethanol drinking in some non-operant conditions and even ethanol-induced sensitization that appear to have a less straightforward involvement of DA signaling (Risinger et al., 1992; Broadbent et al., 1995; Spina et al., 2010; Young et al., 2013). Future research will need to investigate DA-dependent and independent mechanisms by which acetaldehyde might induce behavioral responses via its modulation of the EOS.
Statements
Acknowledgments
This work was supported by grants from Fundación Bancaixa (P1-1A2011-05), Spain.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1
AbrahaoK. P.QuadrosI. M.Souza-FormigoniM. L. (2008). Morphine attenuates the expression of sensitization to ethanol, but opioid antagonists do not. Neuroscience156, 857–864. 10.1016/j.neuroscience.2008.08.012
2
AkilH.OwensC.GutsteinH.TaylorL.CurranE.WatsonS. (1998). Endogenous opioids: overview and current issues. Drug Alcohol Depend.51, 127–140. 10.1016/s0376-8716(98)00071-4
3
AnwerJ.SolimanM. R. (1995). Ethanol-induced alterations in beta-endorphin levels in specific rat brain regions: modulation by adenosine agonist and antagonist. Pharmacology51, 364–369. 10.1159/000139348
4
AragonC. M.AmitZ. (1992). The effect of 3-amino-1,2,4-triazole on voluntary ethanol consumption: evidence for brain catalase involvement in the mechanism of action. Neuropharmacology31, 709–712. 10.1016/0028-3908(92)90150-n
5
AragonC. M.PesoldC. N.AmitZ. (1992b). Ethanol-induced motor activity in normal and acatalasemic mice. Alcohol9, 207–211. 10.1016/0741-8329(92)90055-f
6
AragonC. M.RoganF.AmitZ. (1992a). Ethanol metabolism in rat brain homogenates by a catalase-H2O2 system. Biochem. Pharmacol.44, 93–98. 10.1016/0006-2952(92)90042-h
7
AragonC. M.SpivakK.AmitZ. (1985). Blockade of ethanol induced conditioned taste aversion by 3-amino-1,2,4-triazole: evidence for catalase mediated synthesis of acetaldehyde in rat brain. Life Sci.37, 2077–2084. 10.1016/0024-3205(85)90579-x
8
AriasC.MolinaJ. C.SpearN. E. (2010). Differential role of mu, delta and kappa opioid receptors in ethanol-mediated locomotor activation and ethanol intake in preweanling rats. Physiol. Behav.99, 348–454. 10.1016/j.physbeh.2009.11.012
9
ArizziM. N.CorreaM.BetzA. J.WisnieckiA.SalamoneJ. D. (2003). Behavioral effects of intraventricular injections of low doses of ethanol, acetaldehyde, and acetate in rats: studies with low and high rate operant schedules. Behav. Brain Res.147, 203–210. 10.1016/s0166-4328(03)00158-x
10
Arizzi-LaFranceM. N.CorreaM.AragonC. M.SalamoneJ. D. (2006). Motor stimulant effects of ethanol injected into the substantia nigra pars reticulata: importance of catalase-mediated metabolism and the role of acetaldehyde. Neuropsychopharmacology31, 997–1008. 10.1038/sj.npp.1300849
11
BechtholtA. J.CunninghamC. L. (2005). Ethanol-induced conditioned place preference is expressed through a ventral tagmental area dependent mechanism. Behav. Neurosci.119, 213–223. 10.1037/0735-7044.119.1.213
12
BieB.ZhuW.PanZ. Z. (2009). Ethanol-induced delta-opioid receptor modulation of glutamate synaptic transmission and conditioned place preference in central amygdala. Neuroscience160, 348–358. 10.1016/j.neuroscience.2009.02.049
13
BormannN. M.CunninghamC. L. (1997). The effects of naloxone on expression and acquisition of ethanol place conditioning in rats. Pharmacol. Biochem. Behav.58, 975–982.
14
BoyadjievaN. I.SarkarD. K. (1994). Effects of chronic alcohol on immunoreactive beta-endorphin secretion from hypothalamic neurons in primary cultures: evidence for alcohol tolerance, withdrawal, and sensitization responses. Alcohol. Clin. Exp. Res.18, 1497–1501. 10.1006/mcne.1994.1071
15
BoyadjievaN. I.SarkarD. K. (1997). Effects of ethanol on basal and prostaglandin E1-induced increases in beta-endorphin release and intracellular cAMP levels in hypothalamic cells. Alcohol. Clin. Exp. Res.21, 1005–1009. 10.1111/j.1530-0277.1997.tb04245.x
16
BroadbentJ.GrahameN. J.CunninghamC. L. (1995). Haloperidol prevents ethanol-stimulated locomotor activity but fails to block sensitization. Psychopharmacology120, 475–482. 10.1007/bf02245821
17
BrownZ. W.AmitZ.RockmanG. E. (1979). Intraventricular self-administration of acetaldehyde, but not ethanol, in naive laboratory rats. Psychopharmacology64, 271–276. 10.1007/bf00427509
18
BurattiniC.GillT. M.AicardiG.JanakP. H. (2006). The ethanol self-administration context as a reinstatement cue: acute effects of naltrexone. Neuroscience139, 877–887. 10.1016/j.neuroscience.2006.01.009
19
CacaceS.PlesciaF.BarberiI.CannizzaroC. (2012). Acetaldehyde oral self-administration: evidence from the operant-conflict paradigm. Alcohol. Clin. Exp. Res.36, 1278–1287. 10.1111/j.1530-0277.2011.01725.x
20
CadetP.MantioneK. J.StefanoG. B. (2003). Molecular identification and functional expression of mu 3, a novel alternatively spliced variant of the human mu opiate receptor gene. J. Immunol.170, 5118–5123.
21
CamariniR.Nogueira PiresM. L.CalilH. M. (2000). Involvement of the opioid system in the development and expression of sensitization to the locomotor-activating effect of ethanol. Int. J. Neuropsychopharmacol.3, 303–309. 10.1017/s146114570000211x
22
ChavkinC.JamesI. F.GoldsteinA. (1982). Dynorphin is a specific endogenous ligand of the kappa opioid receptor. Science215, 413–415. 10.1126/science.6120570
23
ChronwallB. M. (1985). Anatomy and physiology of the neuroendocrine arcuate nucleus. Peptides6 (Suppl. 2), 1–11. 10.1016/0196-9781(85)90128-7
24
CiccocioppoR.Martin-FardonR.WeissF. (2002). Effect of selective blockade of mu(1) or delta opioid receptors on reinstatement of alcohol-seeking behavior by drug-associated stimuli in rats. Neuropsychopharmacology27, 391–399. 10.1016/s0893-133x(02)00302-0
25
CiccocioppoR.LinD.Martin-FardonR.WeissF. (2003). Reinstatement of ethanol-seeking behavior by drug cues following single versus multiple ethanol intoxication in the rat: effects of naltrexone. Psychopharmacology168, 208–215. 10.1007/s00213-002-1380-z
26
CorreaM.ArizziM. N.BetzA.MingoteS.SalamoneJ. D. (2003a). Open field locomotor effects in rats after intraventricular injections of ethanol and the ethanol metabolites acetaldehyde and acetate. Brain Res. Bull.62, 197–202. 10.1016/j.brainresbull.2003.09.013
27
CorreaM.ArizziM. N.BetzA.MingoteS.SalamoneJ. D. (2003b). Locomotor stimulant effects of intraventricular injections of low doses of ethanol in rats: acute and repeated administration. Psychopharmacology170, 368–375. 10.1007/s00213-003-1557-0
28
CorreaM.Arizzi-LaFranceM. N.SalamoneJ. D. (2009). Infusions of acetaldehyde into the arcuate nucleus of the hypothalamus induce motor activity in rats. Life Sci.84, 321–327. 10.1016/j.lfs.2008.12.013
29
CorreaM.ManriqueH. M.FontL.EscrigM. A.AragonC. M. (2008). Reduction in the anxiolytic effects of ethanol by centrally formed acetaldehyde: the role of catalase inhibitors and acetaldehyde-sequestering agents. Psychopharmacology200, 455–464. 10.1007/s00213-008-1219-3
30
CorreaM.MiquelM.AragonC. M. (2000). Lead acetate potentiates brain catalase activity and enhances ethanol-induced locomotion in mice. Pharmacol. Biochem. Behav.66, 137–142. 10.1016/s0091-3057(00)00204-5
31
CorreaM.MiquelM.Sanchis-SeguraC.AragonC. M. (1999a). Acute lead acetate administration potentiates ethanol-induced locomotor activity in mice: the role of brain catalase. Alcohol. Clin. Exp. Res.23, 799–805.
32
CorreaM.MiquelM.Sanchis-SeguraC.AragonC. M. (1999b). Effects of chronic lead administration on ethanol-induced locomotor and brain catalase activity. Alcohol19, 43–49. 10.1016/s0741-8329(99)00023-3
33
CorreaM.SalamoneJ. D.SegoviaK. N.PardoM.LongoniR.SpinaL.et al (2012). Piecing together the puzzle of acetaldehyde as a neuroactive agent. Neurosci. Biobehav. Rev.36, 404–430. 10.1016/j.neubiorev.2011.07.009
34
CorreaM.Sanchis-SeguraC.PastorR.AragonC. M. (2004). Ethanol intake and motor sensitization: the role of brain catalase activity in mice with different genotypes. Physiol. Behav.82, 231–40. 10.1016/j.physbeh.2004.03.033
35
CorwinR. L.WojnickiF. H. (2009). Baclofen, raclopride, and naltrexone differentially affect intake of fat and sucrose under limited access conditions. Behav. Pharmacol.20, 537–548. 10.1097/fbp.0b013e3283313168
36
CunninghamC. L.HendersonC. M.BormannN. M. (1998). Extinction of ethanol-induced conditioned place preference and conditioned place aversion: effects of naloxone. Psychopharmacology139, 62–70. 10.1007/s002130050690
37
DayasC. V.LiuX.SimmsJ. A.WeissF. (2007). Distinct patterns of neural activation associated with ethanol seeking: effects of naltrexone. Biol. Psychiatry61, 979–989. 10.1016/j.biopsych.2006.07.034
38
DeA.BoyadjievaN.SarkarD. K. (2002). Role of protein kinase C in control of ethanol-modulated beta-endorphin release from hypothalamic neurons in primary cultures. J. Pharmacol. Exp. Ther.301, 119–128. 10.1124/jpet.301.1.119
39
de WaeleJ. P.KiianmaaK.GianoulakisC. (1994). Spontaneous and ethanol-stimulated in vitro release of beta-endorphin by the hypothalamus of AA and ANA rats. Alcohol. Clin. Exp. Res.18, 1468–1473. 10.1111/j.1530-0277.1994.tb01452.x
40
DempseyS.GriselJ. E. (2012). Locomotor sensitization to EtOH: contribution of β-Endorphin. Front. Mol. Neurosci.5:87. 10.3389/fnmol.2012.00087
41
DevineD. P.LeoneP.WiseR. A. (1993). Mesolimbic dopamine neurotransmission is increased by administration of mu-opioid receptor antagonists. Eur. J. Pharmacol.243, 55–64. 10.1016/0014-2999(93)90167-g
42
Di ChiaraG.NorthR. A. (1992). Neurobiology of opiate abuse. Trends Pharmacol. Sci.13, 185–193. 10.1016/0165-6147(92)90062-b
43
DianaM.PeanaA. T.SircaD.LintasA.MelisM.EnricoP. (2008). Crucial role of acetaldehyde in alcohol activation of the mesolimbic dopamine system. Ann. NY Acad. Sci.1139, 307–317. 10.1196/annals.1432.009
44
EnricoP.SircaD.MereuM.PeanaA. T.LintasA.GolosioA.et al (2009). Acetaldehyde sequestering prevents ethanol-induced stimulation of mesolimbic dopamine transmission. Drug Alcohol Depend.100, 265–271. 10.1016/j.drugalcdep.2008.10.010
45
EvansC. J.KeithD. E. Jr.MorrisonH.MagendzoK.EdwardsR. H. (1992). Cloning of a delta opioid receptor by functional expression. Science258, 1952–1955. 10.1126/science.1335167
46
FemeníaT.ManzanaresJ. (2012). Increased ethanol intake in prodynorphin knockout mice is associated to changes in opioid receptor function and dopamine transmission. Addict. Biol.17, 322–337. 10.1111/j.1369-1600.2011.00378.x
47
FertelR. H.GreenwaldJ. E.SchwarzR.WongL.BianchineJ. (1980). Opiate receptor binding and analgesic effects of the tetrahydroisoquinolines salsolinol and tetrahydropapaveroline. Res. Commun. Chem. Pathol. Pharmacol.27, 3–16.
48
FoddaiM.DosiaG.SpigaS.DianaM. (2004). Acetaldehyde increases dopaminergic neuronal activity in the VTA. Neuropsychopharmacology29, 530–536. 10.1038/sj.npp.1300326
49
FontL.AragonC. M.MiquelM. (2006a). Voluntary ethanol consumption decreases after the inactivation of central acetaldehyde by D-penicillamine. Behav. Brain Res.171, 78–86. 10.1016/j.bbr.2006.03.020
50
FontL.MiquelM.AragonC. (2005). Prevention of ethanol induced behavioral stimulation by D-penicillamine: a sequestration agent for acetaldehyde. Alcohol. Clin. Exp. Res.29, 1156–1164. 10.1097/01.alc.0000171945.30494.af
51
FontL.MiquelM.AragonC. (2006b). Ethanol-induced conditioned place preference, but not aversion, is blocked by treatment with D-penicillamine, an inactivation agent for acetaldehyde. Psychopharmacology184, 56–64. 10.1007/s00213-005-0224-z
52
FontL.MiquelM.AragonC. M. (2008). Involvement of brain catalase activity in the acquisition of ethanol-induced conditioned place preference. Physiol. Behav.93, 733–741. 10.1016/j.physbeh.2007.11.026
53
FroehlichJ. C. (1995). Genetic factors in alcohol self-administration. J. Clin. Psychiatry56(Suppl. 7), 15–23.
54
FroehlichJ. C.ZweifelM.HartsJ.LumengL.LiT. K. (1991). Importance of delta opioid receptors in maintaining high alcohol drinking. Psychopharmacology103, 467–472. 10.1007/bf02244246
55
GevaerdM. S.SultowskiE. T.TakahashiR. N. (1999). Combined effects of diethylpropion and alcohol on locomotor activity of mice: participation of the dopaminergic and opioid systems. Braz. J. Med. Biol. Res.32, 1545–1550. 10.1590/S0100-879X1999001200015
56
GianoulakisC. (1990). Characterization of the effects of acute ethanol administration on the release of beta-endorphin peptides by the rat hypothalamus. Eur. J. Pharmacol.180, 21–29. 10.1016/0014-2999(90)90588-w
57
GianoulakisC. (1993). Endogenous opioids and excessive alcohol consumption. J. Psychiatry Neurosci.18, 148–156.
58
GianoulakisC. (2001). Influence of the endogenous opioid system on high alcohol consumption and genetic predisposition to alcoholism. J. Psychiatry Neurosci.26, 304–318.
59
GianoulakisC.HutchisonW. D.KalantH. (1988). Effects of ethanol treatment and withdrawal on biosynthesis and processing of proopiomelanocortin by the rat neurointermediate lobe. Endocrinology122, 817–825. 10.1210/endo-122-3-817
60
GillK.MenezJ. F.LucasD.DeitrichR. A. (1992). Enzymatic production of acetaldehyde from ethanol in rat brain tissue. Alcohol. Clin. Exp. Res.16, 910–915. 10.1111/j.1530-0277.1992.tb01892.x
61
GremelC. M.YoungE. A.CunninghamC. L. (2011). Blockade of opioid receptors in anterior cingulate cortex disrupts ethanol-seeking behavior in mice. Behav. Brain Res.219, 358–362. 10.1016/j.bbr.2010.12.033
62
HallF. S.SoraI.UhlG. R. (2001). Ethanol consumption and reward are decreased in µ-opiate receptor knockout mice. Psychopharmacology154, 43–49. 10.1007/s002130000622
63
Hamby-MasonR.ChenJ. J.SchenkerS.PerezA.HendersonG. I. (1997). Catalase mediates acetaldehyde formation from ethanol in fetal and neonatal rat brain. Alcohol. Clin. Exp. Res.21, 1063–72. 10.1111/j.1530-0277.1997.tb04255.x
64
HerzA. (1997). Endogenous opioid systems and alcohol addiction. Psychopharmacology129, 99–111. 10.1007/s002130050169
65
HipólitoL.Martí-PratsL.Sánchez-CatalánM. J.PolacheA.GraneroL. (2011). Induction of conditioned place preference and dopamine release by salsolinol in posterior VTA of rats: involvement of μ-opioid receptors. Neurochem. Int.59, 559–562. 10.1016/j.neuint.2011.04.014
66
HipólitoL.Sánchez-CatalánM. J.GraneroL.PolacheA. (2009). Local salsolinol modulates dopamine extracellular levels from rat nucleus accumbens: shell/core differences. Neurochem. Int.55, 187–192. 10.1016/j.neuint.2009.02.014
67
HipólitoL.Sánchez-CatalánM. J.Martí-PratsL.GraneroL.PolacheA. (2012). Revisiting the controversial role of salsolinol in the neurobiological effects of ethanol: old and new vistas. Neurosci. Biobehav. Rev.36, 362–378. 10.1016/j.neubiorev.2011.07.007
68
HipólitoL.Sánchez-CatalánM. J.ZanoliniI.PolacheA.GraneroL. (2008). Shell/core differences in mu- and delta-opioid receptor modulation of dopamine efflux in nucleus accumbens. Neuropharmacology55, 183–189. 10.1016/j.neuropharm.2008.05.012
69
HipólitoL.Sánchez-CatalánM. J.ZornozaT.PolacheA.GraneroL. (2010). Locomotor stimulant effects of acute and repeated intrategmental injections of salsolinol in rats : role of μ-opioid receptors. Psychopharmacology209, 1–11. 10.1007/s00213-009-1751-9
70
HolsteinS. E.PastorR.MeyerP. J.PhillipsT. J. (2005). Naloxone does not attenuate the locomotor effects of ethanol in FAST, SLOW, or two heterogeneous stocks of mice. Psychopharmacology182, 277–289. 10.1007/s00213-005-0066-8
71
HyytiäP.KiianmaaK. (2001). Suppression of ethanol responding by centrally administered CTOP and naltrindole in AA and Wistar rats. Alcohol. Clin. Exp. Res.25, 25–33. 10.1111/j.1530-0277.2001.tb02123.x
72
IngmanK.SalvadoriS.LazarusL.KorpiE. R.HonkanenA. (2003). Selective delta-opioid receptor antagonist N,N(CH3)2-Dmt-Tic-OH does not reduce ethanol intake in alcohol-preferring AA rats. Addict. Biol.8, 173–179. 10.1080/1355621031000117400
73
JamalM.AmenoK.UekitaI.KumihashiM.WangW.IjiriI. (2007). Catalase mediates acetaldehyde formation in the striatum of free-moving rats. Neurotoxicology28, 1245–1248. 10.1016/j.neuro.2007.05.002
74
JarjourS.BaiL.GianoulakisC. (2009). Effect of acute ethanol administration on the release of opioid peptides from the midbrain including the ventral tegmental area. Alcohol. Clin. Exp. Res.33, 1033–1043. 10.1111/j.1530-0277.2009.00924.x
75
JuneH. L.GreyC.Warren-ReeseC.DurrL. F.Ricks-CordA.JohnsonA.et al (1999). The opioid receptor antagonist nalmefene reduces responding maintained by ethanol presentation: preclinical studies in ethanol-preferring and outbred wistar rats. Alcohol. Clin. Exp. Res.22, 2174–2185. 10.1111/j.1530-0277.1998.tb05931.x
76
KarahanianE.QuintanillaM. E.TampierL.Rivera-MezaM.BustamanteD.Gonzalez-LiraV.et al (2011). Ethanol as a prodrug: brain metabolism of ethanol mediates its reinforcing effects. Alcohol. Clin. Exp. Res.35, 606–612. 10.1111/j.1530-0277.2011.01439.x
77
KhachaturianH.LewisM. E.AlessiN. E.WatsonS. J. (1985). Time of origin of opioid peptide-containing neurons in the rat hypothalamus. J. Comp. Neurol.236, 538–546. 10.1002/cne.902360409
78
KiefferB. L.EvansC. J. (2009). Opioid receptors: from binding sites to visible molecules in vivo. Neuropharmacology56(Suppl. 1), 205–212. 10.1016/j.neuropharm.2008.07.033
79
KiefferB. L.Gavériaux-RuffC. (2002). Exploring the opioid system by gene knockout. Prog. Neurobiol.66, 285–306. 10.1016/s0301-0082(02)00008-4
80
KiianmaaK.HoffmanP.TabakoffB. (1983). Antagonism of the behavioral effects of ethanol by naltrexone in BALB/c, C57BL/6, and DBA/2 mice. Psychopharmacology79, 291–294. 10.1007/bf00433403
81
KnappR. J.MalatynskaE.CollinsN.FangL.WangJ. Y.HrubyV. J.et al (1995). Molecular biology and pharmacology of cloned opioid receptors. FASEB J.9, 516–525.
82
KoechlingU. M.AmitZ. (1994). Effects of 3-amino-1,2,4-triazole on brain catalase in the mediation of ethanol consumption in mice. Alcohol11, 235–239. 10.1016/0741-8329(94)90036-1
83
Krishnan-SarinS.PortogheseP. S.LiT. K.FroehlichJ. C. (1995). The delta 2-opioid receptor antagonist naltriben selectively attenuates alcohol intake in rats bred for alcohol preference. Pharmacol. Biochem. Behav.52, 153–159. 10.1016/0091-3057(95)00080-g
84
KuzminA.SandinJ.TereniusL.OgrenS. O. (2003). Acquisition, expression, and reinstatement of ethanol-induced conditioned place preference in mice: effects of opioid receptor-like 1 receptor agonists and naloxone. J. Pharmacol. Exp. Ther.304, 310–318. 10.1124/jpet.102.041350
85
LamM. P.MarinelliP. W.BaiL.GianoulakisC. (2008). Effects of acute ethanol on opioid peptide release in the central amygdala: an in vivo microdialysis study. Psychopharmacology201, 261–271. 10.1007/s00213-008-1267-8
86
LêA. D.PoulosC. X.HardingS.WatchusJ.JuzytschW.ShahamY. (1999). Effects of naltrexone and fluoxetine on alcohol self-administration and reinstatement of alcohol seeking induced by priming injections of alcohol and exposure to stress. Neuropsychopharmacology21, 435–444. 10.1016/s0893-133x(99)00024-x
87
LêA. D.PoulosC. X.QuanB.ChowS. (1993). The effects of selective blockade of delta and mu opiate receptors on ethanol consumption by C57BL/6 mice in a restricted access paradigm. Brain Res.630, 330–332. 10.1016/0006-8993(93)90672-a
88
LericheM.MéndezM. (2010). Ethanol exposure selectively alters beta-endorphin content but not [3H]-DAMGO binding in discrete regions of the rat brain. Neuropeptides44, 9–16. 10.1016/j.npep.2009.11.009
89
LesscherH. M.BaileyA.BurbachJ. P.Van ReeJ. M.KitchenI.GerritsM. A. (2003). Receptor-selective changes in mu-, delta- and kappa-opioid receptors after chronic naltrexone treatment in mice. Eur. J. Neurosci.17, 1006–1012.
90
LiuX.WeissF. (2002). Additive effect of stress and drug cues on reinstatement of ethanol seeking: exacerbation by history of dependence and role of concurrent activation of corticotropin-releasing factor and opioid mechanisms. J. Neurosci.22, 7856–7861.
91
LogripM. L.JanakP. H.RonD. (2009). Blockade of ethanol reward by the kappa opioid receptor. Alcohol43, 359–365. 10.1016/j.alcohol.2009.05.001
92
LucchiL.BosioA.SpanoP. F.TrabucchiM. (1982). Action of ethanol and salsolinol on opiate receptor function. Brain Res.232, 506–510. 10.1016/0006-8993(82)90297-9
93
ManriqueH. M.MiquelM.AragonC. M. (2005). Brain catalase mediates potentiation of social recognition memory produced by ethanol in mice. Drug Alcohol Depend.79, 343–350. 10.1016/j.drugalcdep.2005.02.007
94
MansourA.KhachaturianH.LewisM. E.AkilH.WatsonS. J. (1988). Anatomy of CNS opioid receptors. Trends Neurosci.11, 308–314. 10.1016/0166-2236(88)90093-8
95
MargolisE. B.FieldsH. L.HjelmstadG. O.MitchellJ. M. (2008). Delta-opioid receptor expression in the ventral tegmental area protects against elevated alcohol consumption. J. Neurosci.28, 12672–12681. 10.1523/jneurosci.4569-08.2008
96
MarinelliP. W.FunkD.HardingS.LiZ.JuzytschW.LêA. D. (2009). Roles of opioid receptor subtypes in mediating alcohol seeking induced by discrete cues and context. Eur. J. Neurosci.30, 671–678. 10.1111/j.1460-9568.2009.06851.x
97
MarinelliP. W.QuirionR.GianoulakisC. (2003a). Estradiol valerate and alcohol intake: a comparison between Wistar and Lewis rats and the putative role of endorphins. Behav. Brain Res.139, 59–67. 10.1016/s0166-4328(02)00057-8
98
MarinelliP. W.QuirionR.GianoulakisC. (2003b). A microdialysis profile of beta-endorphin and catecholamines in the rat nucleus accumbens following alcohol administration. Psychopharmacology169, 60–67. 10.1007/s00213-003-1490-2
99
Martí-PratsL.Sánchez-CatalánM. J.HipólitoL.OrricoA.ZornozaT.PolacheA.et al (2010). Systemic administration of D-penicillamine prevents the locomotor activation after intra-VTA ethanol administration in rats. Neurosci. Lett.483, 143–147. 10.1016/j.neulet.2010.07.081
100
MatsuzawaS.SuzukiT.MisawaM. (2000). Involvement of mu-opioid receptor in the salsolinol-associated place preference in rats exposed to conditioned fear stress. Alcohol. Clin. Exp. Res.24, 366–372. 10.1111/j.1530-0277.2000.tb04624.x
101
McBrideW. J.LiT. K.DeitrichR. A.ZimatkinS.SmithB. R.Rodd-HenricksZ. A. (2002). Involvement of acetaldehyde in alcohol addiction. Alcohol. Clin. Exp. Res.26, 114–119.
102
MelisM.EnricoP.PeanaA. T.DianaM. (2007). Acetaldehyde mediates alcohol activation of the mesolimbic dopamine system. Eur. J. Neurosci.26, 2824–33. 10.1111/j.1460-9568.2007.05887.x
103
MéndezM.Morales-MuliaM. (2008). Role of mu and delta opioid receptors in alcohol drinking behaviour. Curr. Drug Abuse Rev.1, 239–252. 10.2174/1874473710801020239
104
MiddaughL. D.BandyA. L. (2000). Naltrexone effects on ethanol consumption and response to ethanol conditioned cues in C57BL/6 mice. Psychopharmacology151, 321–327. 10.1007/s002130000479
105
MiltonG. W.VerhaertP. D.DownerR. G. (1991). Immunofluorescent localization of dopamine-like and leucine-enkephalin-like neurons in the supraoesophageal ganglia of the american cockroach, periplaneta americana. Tissue Cell23, 331–340. 10.1016/0040-8166(91)90051-t
106
MiquelM.FontL.Sanchis-SeguraC.AragonC. M. (2003). Neonatal administration of monosodium glutamate prevents the development of ethanol-but not psychostimulant-induced sensitization: a putative role of the arcuate nucleus. Eur. J. Neurosci.17, 2163–2170. 10.1046/j.1460-9568.2003.02646.x
107
Modesto-LoweV.FritzE. M. (2005). The opioidergic-alcohol link: implications for treatment. CNS Drugs19, 693–707. 10.2165/00023210-200519080-00005
108
MorenoS.MugnainiE.CerùM. P. (1995). Immunocytochemical localization of catalase in the central nervous system of the rat. J. Histochem. Cytochem.43, 1253–1267. 10.1177/43.12.8537642
109
MyersW.NgK.SingerG. (1984). Effects of naloxone and buprenorphine on intravenous acetaldehyde self-injection in rats. Physiol. Behav.33, 449–455. 10.1016/0031-9384(84)90168-9
110
NielsenC. K.SimmsJ. A.PiersonH. B.LiR.SainiS. K.AnanthanS.et al (2008). A novel delta opioid receptor antagonist, SoRI-9409, produces a selective and long-lasting decrease in ethanol consumption in heavy-drinking rats. Biol. Psychiatry64, 974–981. 10.1016/j.biopsych.2008.07.018
111
NylanderI.RomanE. (2012). Neuropeptides as mediators of the early-life impact on the brain; implications for alcohol use disorders. Front. Mol. Neurosci.5:77. 10.3389/fnmol.2012.00077
112
OliveM. F.KoenigH. N.NanniniM. A.HodgeC. W. (2001). Stimulation of endorphin neurotransmission in the nucleus accumbens by ethanol, cocaine, and amphetamine. J. Neurosci.21, RC184.
113
O’MalleyS. S.JaffeA. J.ChangG.SchottenfeldR. S.MeyerR. E.RounsavilleB. (1992). Naltrexone and coping skills therapy for alcohol dependence. A controlled study. Arch. Gen. Psychiatry49, 881–887. 10.1001/archpsyc.1992.01820110045007
114
OrricoA.HipólitoL.Sánchez-CatalánM. J.Martí-PratsL.ZornozaT.GraneroL.et al (2013). Efficacy of D-penicillamine, a sequestering acetaldehyde agent, in the prevention of alcohol relapse-like drinking in rats. Psychopharmacology10.1007/s00213-013-3065-1. [Epub ahead of print]
115
OswaldL. M.WandG. S. (2004). Opioids and alcoholism. Physiol. Behav.81, 339–358. 10.1016/j.physbeh.2004.02.008
116
PasternakG. W. (2001a). The pharmacology of mu analgesics: from patients to genes. Neuroscientist7, 220–231. 10.1177/107385840100700307
117
PasternakG. W. (2001b). Insights into mu opioid pharmacology the role of mu opioid receptor subtypes. Life Sci.68, 2213–229. 10.1016/S0024-3205(01)01008-6
118
PastorR.AragonC. M. (2006). The role of opioid receptor subtypes in the development of behavioral sensitization to ethanol. Neuropsychopharmacology31, 1489–1499. 10.1038/sj.npp.1300928
119
PastorR.AragonC. M. (2008). Ethanol injected into the hypothalamic arcuate nucleus induces behavioral stimulation in rats: an effect prevented by catalase inhibition and naltrexone. Behav. Pharmacol.19, 698–705. 10.1097/fbp.0b013e328315ecd7
120
PastorR.FontL.MiquelM.PhillipsT. J.AragonC. M. (2011). Involvement of the beta-endorphin neurons of the hypothalamic arcuate nucleus in ethanol-induced place preference conditioning in mice. Alcohol. Clin. Exp. Res.35, 2019–2029. 10.1111/j.1530-0277.2011.01553.x
121
PastorR.Sanchis-SeguraC.AragonC. M. (2002). Ethanol-stimulated behaviour in mice is modulated by brain catalase activity and H2O2 rate of production. Psychopharmacology165, 51–59. 10.1007/s00213-002-1241-9
122
PastorR.Sanchis-SeguraC.AragonC. (2005). Effect of selective antagonism of mu(1)-, mu(1/2)-, mu(3)-, and delta-opioid receptors on the locomotor-stimulating actions of ethanol. Drug Alcohol Depend.78, 289–295. 10.1016/j.drugalcdep.2004.11.007
123
PastorcicM.BoyadjievaN.SarkarD. K. (1994). Comparison of the effects of alcohol and acetaldehyde on proopiomelanocortin mRNA levels and beta-endorphin secretion from hypothalamic neurons in primary cultures. Mol. Cell. Neurosci.5, 580–586. 10.1006/mcne.1994.1071
124
PatelV. A.PohoreckyL. A. (1989). Acute and chronic ethanol treatment on beta-endorphin and catecholamine levels. Alcohol6, 59–63. 10.1016/0741-8329(89)90074-8
125
PautassiR. M.NizhnikovM. E.AcevedoM. B.SpearN. E. (2012). Early role of the κ opioid receptor in ethanol-induced reinforcement. Physiol. Behav.105, 1231–1241. 10.1016/j.physbeh.2012.01.003
126
PautassiR. M.NizhnikovM. E.FabioM. C.SpearN. E. (2011). An acetaldehyde-sequestering agent inhibits appetitive reinforcement and behavioral stimulation induced by ethanol in preweanling rats. Pharmacol. Biochem. Behav.97, 462–469. 10.1016/j.pbb.2010.10.005
127
PeanaA. T.AssarettiA. R.MuggironiG.EnricoP.DianaM. (2009). Reduction of ethanol-derived acetaldehyde induced motivational properties by L-cysteine. Alcohol. Clin. Exp. Res.33, 43–48. 10.1111/j.1530-0277.2008.00809.x
128
PeanaA. T.EnricoP.AssarettiA. R.PuligheE.MuggironiG.NiedduM.et al (2008). Key role of ethanol-derived acetaldehyde in the motivational properties induced by intragastric ethanol: a conditioned place preference study in the rat. Alcohol. Clin. Exp. Res.32, 249–258. 10.1111/j.1530-0277.2007.00574.x
129
PeanaA. T.MuggironiG.DianaM. (2010). Acetaldehyde-reinforcing effects; a study on oral self-administration behavior. Front. Psychiatry1:23. doi: 10.3389/fpsyt.2010.00023
130
PeanaA. T.MuriggironiG.FoisG. R.ZinelluM.SircaD.DianaM. (2012). Effect of (L)-cysteine on acetaldehyde self-administration. Alcohol46, 489–497. 10.1016/j.alcohol.2011.10.004
131
PeanaA. T.MuggironiG.FoisG. R.ZinelluM.VinciS.AcquasE. (2011). Effect of opioid receptor blockade on acetaldehyde self-administration and ERK phosphorylation in the rat nucleus accumbens. Alcohol45, 773–783. 10.1016/j.alcohol.2011.06.003
132
PeciñaS.BerridgeK. C. (2005). Hedonic hot spot in nucleus accumbens shell: where do mu-opioids cause increased hedonic impact of sweetness?. J. Neurosci.25, 11777–11786. 10.1523/jneurosci.2329-05.2005
133
PoppR. L.EricksonC. K. (1998). The effect of an acute ethanol exposure on the rat brain POMC opiopeptide system. Alcohol16, 139–148. 10.1016/s0741-8329(98)00003-2
134
QuertemontE.De WitteP. (2001). Conditioned stimulus preference after acetaldehyde but not ethanol injections. Pharmacol. Biochem. Behav.68, 449–454. 10.1016/s0091-3057(00)00486-x
135
QuertemontE.TambourS.TirelliE. (2005). The role of acetaldehyde in the neurobehavioral effects of ethanol: a comprehensive review of animal studies. Prog. Neurobiol.75, 247–274. 10.1016/j.pneurobio.2005.03.003
136
RaoR. E.WojnickiF. H.CouplandJ.GhoshS.CorwinR. L. (2008). Baclofen, raclopride, and naltrexone differentially reduce solid fat emulsion intake under limited access conditions. Pharmacol. Biochem. Behav.89, 581–590. 10.1016/j.pbb.2008.02.013
137
RasmussenD. D.BoldtB. M.WilkinsonC. W.MittonD. R. (2002). Chronic daily ethanol and withdrawal: 3. Forebrain pro-opiomelanocortin gene expression and implications for dependence, relapse, and deprivation effect. Alcohol. Clin. Exp. Res.26, 535–546. 10.1111/j.1530-0277.2002.tb02572.x
138
RasmussenD. D.BryantC. A.BoldtB. M.ColasurdoE. A.LevinN.WilkinsonC. W. (1998). Acute alcohol effects on opiomelanocortinergic regulation. Alcohol. Clin. Exp. Res.22, 789–801. 10.1111/j.1530-0277.1998.tb03870.x
139
RaynorK.KongH.ChenY.YasudaK.YuL.BellG. I.et al (1994). Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors. Mol. Pharmacol.45, 330–334.
140
ReddyB. V.SarkarD. K. (1993). Effect of alcohol, acetaldehyde, and salsolinol on beta-endorphin secretion from the hypothalamic neurons in primary cultures. Alcohol. Clin. Exp. Res.17, 1261–1267. 10.1111/j.1530-0277.1993.tb05239.x
141
ReddyB. V.BoyadjievaN.SarkarD. K. (1995). Effect of ethanol, propanol, butanol, and catalase enzyme blockers on beta-endorphin secretion from primary cultures of hypothalamic neurons: evidence for a mediatory role of acetaldehyde in ethanol stimulation of beta-endorphin release. Alcohol. Clin. Exp. Res.19, 339–344. 10.1111/j.1530-0277.1995.tb01512.x
142
RisingerF. O.DickinsonS. D.CunninghamC. L. (1992) Haloperidol reduces ethanol-induced motor activity stimulation but not conditioned place preference. Psychopharmacology107, 453–456. 10.1007/bf02245175
143
RobertsA. J.McDonaldJ. S.HeyserC. J.KiefferB. L.MatthesH. W.KoobG. F.et al (2000). Mu-Opioid receptor knockout mice do not self-administer alcohol. J. Pharmacol. Exp. Ther.293, 1002–1008.
144
RoddZ.BellR. L.ZhangY.MurphyJ. M.GoldsteinA.ZaffaroniA.et al (2005). Regional heterogeneity for the intracranial self-administration of ethanol and acetaldehyde within the ventral tegmental area of alcohol-preferring (P) rats: involvement of dopamine and serotonin. Neuropsychopharmacology30, 330–338. 10.1038/sj.npp.1300561
145
Rodd-HenricksZ. A.MelendezR. IZaffaroniA.GoldsteinA.McBrideW. J.LuT. K. (2002). The reinforcing effects of acetaldehyde in the posterior ventral tegmental area of alcohol-preferring rats. Pharmacol. Biochem. Behav.72, 55–64. 10.1016/s0091-3057(01)00733-x
146
Roth-DeriI.Green-SadanT.YadidG. (2008). Beta-endorphin and drug-induced reward and reinforcement. Prog. Neurobiol.86, 1–21. 10.1016/j.pneurobio.2008.06.003
147
Sánchez-CatalánM. J.HipólitoL.ZornozaT.PolacheA.GraneroL. (2009). Motor stimulant effects of ethanol and acetaldehyde injected into the posterior ventral tegmental area of rats: role of opioid receptors. Psychopharmacology204, 641–653. 10.1007/s00213-009-1495-6
148
Sanchis-SeguraC.CorreaM.AragonC. M. (2000). Lession on the hypothalamic arcuate nucleus by estradiol valerate results in a blockade of ethanol-induced locomotion. Behav. Brain Res.114, 57–63. 10.1016/s0166-4328(00)00183-2
149
Sanchis-SeguraC.CorreaM.MiquelM.AragonC. M. (2005b). Catalase inhibition in the arcuate nucleus blocks ethanol effects on the locomotor activity of rats. Neurosci. Lett.376, 66–70. 10.1016/j.neulet.2004.11.025
150
Sanchis-SeguraC.GriselJ. E.OliveM. F.GhozlandS.KoobG. F.RobertsA. J.et al (2005a). Role of the endogenous opioid system on the neuropsychopharmacological effects of ethanol: new insights about an old question. Alcohol. Clin. Exp. Res.29, 1522–1527. 10.1097/01.alc.0000174913.60384.e8
151
Sanchis-SeguraC.MiquelM.CorreaM.AragonC. M. (1999a). Daily injections of cyanamide enhance both ethanol-induced locomotion and brain catalase activity. Behav. Pharmacol.10, 459–465. 10.1097/00008877-199909000-00004
152
Sanchis-SeguraC.MiquelM.CorreaM.AragonC. M. (1999b). The catalase inhibitor sodium azide reduces ethanol-induced locomotor activity. Alcohol19, 37–42. 10.1016/s0741-8329(99)00016-6
153
Sanchis-SeguraC.MiquelM.CorreaM.AragonC. M. (1999c). Cyanamide reduces brain catalase and ethanol-induced locomotor activity: is there a functional link? Psychopharmacology144, 83–89. 10.1007/s002130050980
154
Sanchis-SeguraC.PastorR.AragonC. M. (2004). Opposite effects of acute versus chronic naltrexone administration on ethanol-induced locomotion. Behav. Brain Res.153, 61–67. 10.1016/j.bbr.2003.11.003
155
SchulzR.WüsterM.DukaT.HerzA. (1980). Acute and chronic ethanol treatment changes endorphin levels in brain and pituitary. Psychopharmacology68, 221–227. 10.1007/bf00428107
156
SeizingerB. R.BovermannK.MaysingerD.HölltV.HerzA. (1983). Differential effects of acute and chronic ethanol treatment on particular opioid peptide systems in discrete regions of rat brain and pituitary. Pharmacol. Biochem. Behav.18(Suppl. 1), 361–369. 10.1016/0091-3057(83)90200-9
157
SeizingerB. R.HölltV.HerzA. (1984). Effects of chronic ethanol treatment on the in vitro biosynthesis of pro-opiomelanocortin and its posttranslational processing to beta-endorphin in the intermediate lobe of the rat pituitary. J. Neurochem.43, 607–613. 10.1111/j.1471-4159.1984.tb12778.x
158
SimmsJ. A.SteenslandP.MedinaB.AbernathyK. E.ChandlerL. J.WiseR.et al (2008). Intermittent access to 20% ethanol induces high ethanol consumption in Long-Evans and Wistar rats. Alcohol. Clin. Exp. Res.32, 1816–1823. 10.1111/j.1530-0277.2008.00753.x
159
SimonE. J. (1991). Opioid receptors and endogenous opioid peptides. Med. Res. Rev.11, 357–374. 10.1002/med.2610110402
160
SircaD.EnricoP.MereuM.PeanaA. T.DianaM. (2011). L-cysteine prevents ethanol-induced stimulation of mesolimbic dopamine transmission. Alcohol. Clin. Exp. Res.35, 862–869. 10.1111/j.1530-0277.2010.01416.x
161
SmithB. R.AmitZ.SplawinskyJ. (1984). Conditioned place preference induced by intraventricular infusions of acetaldehyde. Alcohol1, 193–195. 10.1016/0741-8329(84)90097-1
162
SmithB. R.AragonC. M. G.AmitZ. (1997). Catalase and the production of central acetaldehyde: a possible mediator of the psychopharmacological effects of ethanol. Addict. Biol.2, 277–289. 10.1080/13556219772570
163
SpanagelR.HerzA.ShippenbergT. S. (1992). Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc. Natl. Acad. Sci. U S A89, 2046–2050. 10.1073/pnas.89.6.2046
164
SpinaL.LongoniR.VinciS.IbbaF.PeanaA. T.MuggironiG.et al (2010). Role of dopamine D1 receptors and extracellular signal regulated kinase in the motivational properties of acetaldehyde as assessed by place preference conditioning. Alcohol. Clin. Exp. Res.34, 607–616. 10.1111/j.1530-0277.2009.01129.x
165
StinusL.KoobG. F.LingN.BloomF. E.Le MoalM. (1980). Locomotor activation induced by infusion of endorphins into the ventral tegmental area: evidence for opiate-dopamine interactions. Proc. Natl. Acad. Sci. U S A77, 2323–2327. 10.1073/pnas.77.4.2323
166
TarragónE.BaliñoP.AragonC. M.PastorR. (2012). Ethanol drinking-in-the-dark facilitates behavioral sensitization to ethanol in C57BL/6J, BALB/cByJ, but not in mu-opioid receptor deficient CXBK mice. Pharmacol. Biochem. Behav.101, 14–23. 10.1016/j.pbb.2011.11.014
167
ThorsellA. (2013). The μ-opioid receptor and treatment response to naltrexone. Alcohol Alcohol.48, 402–408. 10.1093/alcalc/agt030
168
TrigoJ. M.Martin-GarcíaE.BerrenderoF.RobledoP.MaldonadoR. (2010). The endogenous opioid system: a common substrate in drug addiction. Drug Alcohol Depend.108, 183–194. 10.1016/j.drugalcdep.2009.10.011
169
UnterwaldE. M.AntonB.ToT.LamH.EvansC. J. (1998). Quantitative immunolocalization of mu opioid receptors: regulation by naltrexone. Neuroscience85, 897–905. 10.1016/s0306-4522(97)00659-3
170
VengelieneV.BilbaoA.MolanderA.SpanagelR. (2008). Neuropharmacology of alcohol addiction. Br. J. Pharmacol.154, 299–315. 10.1038/bjp.2008.30
171
VinciS.IbbaF.LongoniR.SpinaL.SpigaS.AcquasE. (2010). Acetaldehyde elicits ERK phosphorylation in the rat nucleus accumbens and extended amygdala. Synapse64, 916–927. 10.1002/syn.20811
172
WalkerB. M.ValdezG. R.McLaughlinJ. P.BakalkinG. (2012). Targeting dynorphin/kappa opioid receptor systems to treat alcohol abuse and dependence. Alcohol46, 359–370. 10.1016/j.alcohol.2011.10.006
173
WandG. S. (1990). Differential regulation of anterior pituitary corticotrope function is observed in vivo but not in vitro in two lines of ethanol-sensitive mice. Alcohol. Clin. Exp. Res.14, 100–106. 10.1111/j.1530-0277.1990.tb00454.x
174
WeeS.KoobG. F. (2010). The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse. Psychopharmacology210, 121–135. 10.1007/s00213-010-1825-8
175
WongK. J.WojnickiF. H.CorwinR. L. (2009). Baclofen, raclopride, and naltrexone differentially affect intake of fat/sucrose mixtures under limited access conditions. Pharmacol. Biochem. Behav.92, 528–536. 10.1016/j.pbb.2009.02.002
176
XieG.HipólitoL.ZuoW.PolacheA.GraneroL.KrnjevicK.et al (2012). Salsolinol stimulates dopamine neurons in slices of posterior ventral tegmental area indirectly by activating-opioid receptors. J. Pharmacol. Exp. Ther.341, 43–50. 10.1124/jpet.111.186833
177
YoungE. A.DreumontS. E.CunninghamC. L. (2013). Role of nucleus accumbens dopamine receptor subtypes in the learning and expression of alcohol-seeking behavior. Neurobiol. Learn. Mem.10.1016/j.nlm.2013.05.004. [Epub ahead of print]
178
ZimatkinS. M.LindrosK. O. (1996). Distribution of catalase in rat brain: aminergic neurons as possible targets for ethanol effects. Alcohol Alcohol.31, 167–174. 10.1093/oxfordjournals.alcalc.a008128
179
ZimatkinS. M.RoutU. K.KoivusaloM.BühlerR.LindrosK. O. (1992). Regional distribution of low-Km mitochondrial aldehyde dehydrogenase in the rat central nervous system. Alcohol. Clin. Exp. Res.16, 1162–1167. 10.1111/j.1530-0277.1992.tb00713.x
Summary
Keywords
ethanol, acetaldehyde, endogenous opioid system, salsolinol, behavior, animal
Citation
Font L, Luján MÁ and Pastor R (2013) Involvement of the endogenous opioid system in the psychopharmacological actions of ethanol: the role of acetaldehyde. Front. Behav. Neurosci. 7:93. doi: 10.3389/fnbeh.2013.00093
Received
03 May 2013
Accepted
10 July 2013
Published
31 July 2013
Volume
7 - 2013
Edited by
Merce Correa, University Jaume I, Spain
Reviewed by
Elio Acquas, University of Cagliari, Italy
María J. Sánchez-Catalán, Centre National de Recherche Scientifique (CNRS), Institute of Cellular and Integrative Neurosciences (INCI) UPR3212, France
Copyright
© Font, Luján and Pastor.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Laura Font, Area de Psicobiología, Universitat Jaume I, Avda. Sos Baynat s/n, 12071, Castellón, Spain e-mail: laura.font@uji.es
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.